Implementing essential interventions for cardiovascular disease risk management in primary healthcare: lessons from Eastern Europe and Central Asia.
cardiovascular disease
health systems
public health
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
10
2019
revised:
12
01
2020
accepted:
13
01
2020
entrez:
6
3
2020
pubmed:
7
3
2020
medline:
7
3
2020
Statut:
epublish
Résumé
Globally, non-communicable diseases (NCDs) are the leading cause of morbidity and mortality, including in the WHO European region. Within this region, the Member States with the greatest cardiovascular disease (CVD) burden are also some of the lowest resourced. As the need for technical support for the implementation of essential CVD/NCD interventions in primary healthcare (PHC) in these regions grew urgent, the WHO Regional Office for Europe has been directly supporting national governments in the development, assessment, scale-up and quality improvement of large scale PHC interventions for CVD. Herein, we synthesise the key learnings from providing technical support to national governments under the auspices of the WHO across the European region and share these learnings as a resource for public health professionals to consider when increasing coverage of quality essential health services. Based on our experience providing technical support to a diversity of Member States in the European Region (eg, Tajikistan, Republic of Moldova, Ukraine and Uzbekistan), we have identified six key lessons: prioritising NCDs for public health intervention, identifying and mapping existing resources, engaging key stakeholders, tailoring interventions to the local health system, generating local evidence and ensuring quality improvement while mainstreaming. Common challenges across all phases of implementation include multiple and inconsistent international toolkits and guidance, lack of national capacity for evidence-based healthcare, limited access to essential medicines and technologies, inconsistent national guidelines and limited experience in evaluation methodology, clinical epidemiology and guideline implementation. We map the lessons to the Consolidated Framework for Implementation Research and highlight key learnings and challenges specific to the region. Member States in the region are at various stages of implementation; however, several are currently conducting pragmatic clinical trials to generate local evidence for health policy. As this work expands, greater engagement with peer-to-peer sharing of contextual wisdom, sharing of resources, publishing methodology and results and development of region-specific resources is planned.
Identifiants
pubmed: 32133194
doi: 10.1136/bmjgh-2019-002111
pii: bmjgh-2019-002111
pmc: PMC7042567
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e002111Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
BMJ Qual Saf. 2016 Oct;25(10):803-7
pubmed: 26893512
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Circulation. 2015 Oct 27;132(17):1667-78
pubmed: 26503749
Int J Med Educ. 2016 Sep 24;7:309-319
pubmed: 27716612
Confl Health. 2017 Jul 17;11:14
pubmed: 28725259
F1000Res. 2019 Sep 13;8:1639
pubmed: 32953086
BMJ. 2008 May 31;336(7655):1241-5
pubmed: 18511799
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
F1000Res. 2016 Oct 14;5:2522
pubmed: 28357040
BMJ Open. 2019 Jul 4;9(7):e025705
pubmed: 31278091
Am J Public Health. 2016 Jan;106(1):74-8
pubmed: 26696288